Measuring health-related quality of life in older patient populations Anne HickeyMaja BarkerCiaran O’Boyle Review Article 17 September 2012 Pages: 971 - 993
Pharmacological management of overactive bladder Denis GetsiosWissam El-HadiJ. Jaime Caro Review Article 17 September 2012 Pages: 995 - 1006
The cost effectiveness of orlistat in a 1-year weight-management programme for treating overweight and obese patients in Sweden Peter Hertzman Original Research Article 17 September 2012 Pages: 1007 - 1020
Using policy simulation to predict drug plan expenditure when planning reimbursement changes Colin R. DormuthSean BurnettSebastian Schneeweiss Original Research Article 17 September 2012 Pages: 1021 - 1030
Economic analysis of on-demand maintenance therapy with proton pump inhibitors in patients with non-erosive reflux disease Dyfrig A. HughesKeith BodgerDominique Dubois Original Research Article 17 September 2012 Pages: 1031 - 1041
Financial impact of two different ways of evaluating early virological response to peginterferon-α-2b plus ribavirin therapy in treatment-naive patients with chronic hepatitis C virus genotype 1 Maria ButiMiguel A. CasadoRafael Esteban Original Research Article 17 September 2012 Pages: 1043 - 1055
Eplerenone Katherine F. CroomGreg L. Plosker Adis Pharmacoeconomic Drug Evaluation 17 September 2012 Pages: 1057 - 1072